Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177Paul D. Brown, Jan C. Buckner, John W. Kugler et al.|Journal of Clinical Oncology|2008Cited by 275
An ERK5-NRF2 Axis Mediates Senescence-Associated Stemness and AtherosclerosisJun‐ichi Abe, Sivareddy Kotla, Masaki Imanishi et al.|Circulation Research|2023Cited by 39
Immunomodulatory Effects of Gold Nanoparticles: Impacts on Immune Cells and Mechanisms of ActionKhadijeh Koushki, Sunil Krishnan, Prapannajeet Biswal et al.|Nanomaterials|2025Cited by 15
Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent GlioblastomaKshama Gupta, Sunil Krishnan|Frontiers in Oncology|2022Cited by 13
Premature senescence and cardiovascular disease following cancer treatments: mechanistic insightsAshita Jain, Nhat-Tu Le, Diego Casanova et al.|Frontiers in Cardiovascular Medicine|2023Cited by 9